Active, Not Recruiting
A Phase II Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy
NCT07176702
- Conditions
- Anophthalmia with pulmonary hypoplasia, HER2-positive Status, Metastatic PDAC
- Locations
-
- Nanjing Drum Tower Hospital Nanjing, China
- Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China